Based on these findings, we propose that the combination L30I40 inhibits breast cancer cell proliferation by both inducing the G1 cell cycle arrest through disruption of cyclin D1-CDK4/6 complex activities and enhancing cell apoptosis through regulating protein levels of Bcl-xL and Bax (Figure 2G). Here, CDK4 is linked to breast carcinoma.